January 12, 2018 / 2:36 PM / in 27 minutes BRIEF-BD Statement On FDA Warning Letter For Preanalytical Systems Business Unit Reuters Staff 
Jan 12 (Reuters) - Becton Dickinson And Co: 
* BD STATEMENT ON FDA WARNING LETTER FOR PREANALYTICAL SYSTEMS BUSINESS UNIT 
* BECTON DICKINSON - AFTER FDA INSPECTION IN JULY, TOOK ACTION THAT CO BELIEVED FULLY ADDRESSED AGENCY‘S INSPECTIONAL OBSERVATIONS 
* BECTON DICKINSON - “CAREFULLY REVIEWING” FDA‘S FEEDBACK OUTLINED IN LETTER WITH HIGHEST SENSE OF URGENCY, TO PROVIDE FULL RESPONSE ON OR BEFORE FEB 1 Source text for Eikon: Further company coverage: